IPC The Hospitalist Company Upgraded by RBC Capital to “Outperform” (IPCM)
IPC The Hospitalist Company (NASDAQ:IPCM) was upgraded by equities research analysts at RBC Capital from a “sector perform” rating to an “outperform” rating in a research note issued to investors on Friday, TheFlyOnTheWall.com reports. The firm currently has a $52.00 price objective on the stock, up from their previous price objective of $49.00. RBC Capital’s price target would suggest a potential upside of 26.55% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated a “neutral” rating on shares of IPC The Hospitalist Company in a research note on Wednesday, June 18th. They now have a $42.00 price target on the stock, down previously from $50.00. Separately, analysts at Wells Fargo & Co. upgraded shares of IPC The Hospitalist Company from a “market perform” rating to an “outperform” rating in a research note on Friday, April 25th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $52.22.
Shares of IPC The Hospitalist Company (NASDAQ:IPCM) traded up 8.30% on Friday, hitting $44.50. The stock had a trading volume of 325,011 shares. IPC The Hospitalist Company has a 52-week low of $38.13 and a 52-week high of $63.70. The stock’s 50-day moving average is $41.8 and its 200-day moving average is $49.67. The company has a market cap of $762.3 million and a price-to-earnings ratio of 17.41.
IPC The Hospitalist Company (NASDAQ:IPCM) last announced its earnings results on Wednesday, April 23rd. The company reported $0.57 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.64 by $0.07. The company had revenue of $172.73 million for the quarter, compared to the consensus estimate of $183.00 million. During the same quarter last year, the company posted $0.57 earnings per share. IPC The Hospitalist Company’s revenue was up 12.8% compared to the same quarter last year. Analysts expect that IPC The Hospitalist Company will post $2.40 EPS for the current fiscal year.
In other IPC The Hospitalist Company news, Insider Devra G. Shapiro sold 27,314 shares of IPC The Hospitalist Company stock on the open market in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $40.04, for a total transaction of $1,093,652.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
IPC The Hospitalist Company, Inc (NASDAQ:IPCM) is a provider of hospitalist services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.